Abstract:
The present invention provides novel hydroxamic acid derivatives represented by the compound of formula (I), or pharmaceutical acceptable salts thereof, wherein the compounds of the present invention inhibit various enzymes from the matrix metalloproteinase family, including collagenase, stromelysin, and gelatinase, and hence are useful for the treatment of matrix metallo endoproteinase diseases such as osteoarthrits, rheumatoid arthritis, septic arthritis, osteopenias such as osteoporosis, tumor metastasis (invasion and growth), periodontitis, gingivitis, corneal ulceration, dermal ulceration, gastric ulceration, and other diseases related to connective tissue degradation.
Abstract:
Compounds of the formula (I): R -SO2-O-Q, their isomeric forms and salts thereof, wherein Q is the group (a), G is selected from the group S, S(=O), S(=O)2, C=S and C=O; R is selected from the group C1-C3 alkyl and C1-C3 haloalkyl; R , R , R , R , R , R and R are various substituents. Arthropodicidal and nematocidal compositions comprising the compounds of formula (I).
Abstract:
Pharmaceutical compositions and methods of using CCK-ligands as antipsychotic, antianxiety, and agents useful in treatment or prevention of withdrawal symptoms caused by withdrawal of chronic or long-term use of diazepam, alcohol, cocaine, or nicotine, and antianxiety agents are described.